+1 212 479 6712 dayne.brown@cooley.com
Dayne Brown has a broad corporate practice. She counsels technology and life sciences companies on transactions from formation through exit.
Download full bio
Prevail Therapeutics $125 Million IPO
Gamida Cell – $50 Million IPO
MeiraGTx – $75 Million IPO
Zealand Pharma – $89 Million IPO
Emerging Companies
Mergers & Acquisitions
Capital Markets
Venture Capital
University of ChicagoJD, 2014
University of WashingtonBA, English Literature & International Studies2005
New York
Washington
Aquestive – $74 Million IPO September 12, 2018
Vimeo to Acquire Livestream September 26, 2017
Zealand Pharma – $89 Million IPO August 25, 2017
+1 212 479 6712 office dayne.brown@cooley.com
55 Hudson YardsNew York, NY 10001-2157